| Mr Jean Guy Fortin, MD | |
|
2800 Ross Clark Circle, Dothan, AL 36301 | |
| (334) 793-2211 | |
| (334) 793-7161 |
| Full Name | Mr Jean Guy Fortin |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 52 Years |
| Location | 2800 Ross Clark Circle, Dothan, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205945276 | NPI | - | NPPES |
| 000046580 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 00009017 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Partners Pc | 8123016334 | 24 |
| Eye Partners Pc | 8123016334 | 24 |
News Archive
Glide Pharma® today announced the award of a sub-contract from Pfenex Inc. to develop a solid formulation containing the recombinant Protective Antigen (rPA) from Bacillus anthracis expressed in Pfēnex Expression Technology™ suitable for delivery with the Glide SDI® (solid dose injector). This approach will address two important logistical constraints of the currently available vaccine, namely, long term stability during storage and ease of administration.
A surprising discovery about a rare form of childhood brain cancer suggests a new treatment approach for that cancer and, potentially, many others.
A new study by a team of British researchers has found a link between cot deaths and mothers who smoke.
UT Southwestern Medical Center researchers have determined the specific type of cell that gives rise to large, disfiguring tumors called plexiform neurofibromas, a finding that could lead to new therapies for preventing growth of these tumors.
› Verified 4 days ago
| Entity Name | Eye Partners Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902837453 PECOS PAC ID: 8123016334 Enrollment ID: O20040505001088 |
News Archive
Glide Pharma® today announced the award of a sub-contract from Pfenex Inc. to develop a solid formulation containing the recombinant Protective Antigen (rPA) from Bacillus anthracis expressed in Pfēnex Expression Technology™ suitable for delivery with the Glide SDI® (solid dose injector). This approach will address two important logistical constraints of the currently available vaccine, namely, long term stability during storage and ease of administration.
A surprising discovery about a rare form of childhood brain cancer suggests a new treatment approach for that cancer and, potentially, many others.
A new study by a team of British researchers has found a link between cot deaths and mothers who smoke.
UT Southwestern Medical Center researchers have determined the specific type of cell that gives rise to large, disfiguring tumors called plexiform neurofibromas, a finding that could lead to new therapies for preventing growth of these tumors.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jean Guy Fortin, MD 2800 Ross Clark Circle, Dothan, AL 36301 Ph: (334) 793-2211 | Mr Jean Guy Fortin, MD 2800 Ross Clark Circle, Dothan, AL 36301 Ph: (334) 793-2211 |
News Archive
Glide Pharma® today announced the award of a sub-contract from Pfenex Inc. to develop a solid formulation containing the recombinant Protective Antigen (rPA) from Bacillus anthracis expressed in Pfēnex Expression Technology™ suitable for delivery with the Glide SDI® (solid dose injector). This approach will address two important logistical constraints of the currently available vaccine, namely, long term stability during storage and ease of administration.
A surprising discovery about a rare form of childhood brain cancer suggests a new treatment approach for that cancer and, potentially, many others.
A new study by a team of British researchers has found a link between cot deaths and mothers who smoke.
UT Southwestern Medical Center researchers have determined the specific type of cell that gives rise to large, disfiguring tumors called plexiform neurofibromas, a finding that could lead to new therapies for preventing growth of these tumors.
› Verified 4 days ago
Dr. Aric J Aldridge, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1450 Ross Clark Cir Ste 100, Dothan, AL 36301 Phone: 334-479-0043 Fax: 334-479-0048 | |
Dr. Ronald P. Swendris, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2800 Ross Clark Cir, Dothan, AL 36301 Phone: 334-793-2211 Fax: 334-793-7161 | |
Dr. Harsha A. Sen, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2800 Ross Clark Cir, Dothan, AL 36301 Phone: 334-793-2211 Fax: 334-793-7161 | |
William Timothy Gannon, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2664 Hartford Hwy, Dothan, AL 36305 Phone: 334-699-2244 Fax: 334-699-2245 | |
Dr. Jorge L Arango, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 160 Healthwest Dr, Dothan, AL 36303 Phone: 334-793-2211 Fax: 334-793-7161 | |
Dr. Andrew F Dannemann, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1909 Honeysuckle Rd, Suite 2, Dothan, AL 36305 Phone: 334-699-7100 Fax: 334-699-7410 |